(EMAILWIRE.COM, July 26, 2015 ) This report provides comprehensive information on the therapeutic development for Refractory Leukemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule…
http://www.emailwire.com/release/193582-Refractory-Leukemia-cancer-Pipeline-Review-H1-2015.html















